Scale-Up Synthesis and Identification of GLYX-13, a NMDAR Glycine-Site Partial Agonist for the Treatment of Major Depressive Disorder.

MLA

Li, Wenchao, et al. “Scale-Up Synthesis and Identification of GLYX-13, a NMDAR Glycine-Site Partial Agonist for the Treatment of Major Depressive Disorder.” Molecules, vol. 23, no. 5, May 2018, p. 996. EBSCOhost, https://doi.org/10.3390/molecules23050996.

APA

Li, W., Liu, J., Fan, M., Li, Z., Chen, Y., Zhang, G., Huang, Z., & Zhang, L. (2018). Scale-Up Synthesis and Identification of GLYX-13, a NMDAR Glycine-Site Partial Agonist for the Treatment of Major Depressive Disorder. Molecules, 23(5), 996. https://doi.org/10.3390/molecules23050996

Chicago

Li, Wenchao, Jingjian Liu, Minghua Fan, Zhongtang Li, Yin Chen, Guisen Zhang, Zhuo Huang, and Liangren Zhang. 2018. “Scale-Up Synthesis and Identification of GLYX-13, a NMDAR Glycine-Site Partial Agonist for the Treatment of Major Depressive Disorder.” Molecules 23 (5): 996. doi:10.3390/molecules23050996.